CRO Syneos Health hires new CEO

The contract research organization (CRO) Syneos Health has promoted Michelle Keefe to be its CEO and a member of its board.

Keefe was previously the president, medical affairs and commercial solutions at Morrisville, North Carolina-based Syneos.

The company’s departing CEO, Alistair Macdonald, is retiring after working at the company for two decades.

Macdonald will serve as an advisor to the company until March 2023.

Michelle Keefe

Keefe has more than three decades of experience working in the life sciences, including two decades at Pfizer.

“I am incredibly honored to take on this role and lead our talented colleagues around the globe,” Keefe wrote in a LinkedIn post. “I look forward to leveraging my decades of life sciences industry experience to help usher Syneos Health into its next chapter as a data- and insights-driven organization, addressing market opportunities with a prod…

Read more
  • April 29, 2022
  • 0

Phastar wins investment from Charterhouse Capital Partners

The contract research organization Phastar (London) plans to expand its statistics and data science services with funding from Charterhouse Capital Partners, a European private equity firm. Phastar will also use the funds to expand its international footprint, opening an office in China.

“We continue to see strong growth across pharma and biotech services,” said Kevin Kane, CEO of Phastar over email. “Pharma companies are looking to specialist suppliers with experienced staff to provide functional service provision (FSP) services as the larger full-service CROs fail to deliver on quality, and biotechs continue to need strong statistical and data science support for their drug development projects, recognizing that experts in these areas can design better trial programs with fewer patients.

The company already had operations in the U.S., U.K, continental Europe, Africa, Japan and Australia. Last year, the firm opened offices in San Diego and To…

Read more
  • January 12, 2021
  • 0